Business Wire
11 Jun 2026, 03:29 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
A class action lawsuit has been filed against ADMA Biologics on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. — Class action lawsuits create legal uncertainty and potential financial liabilities, which typically weigh on a company's stock price.
-0.60Which stocks this story touches
The company is facing a class action lawsuit filed on behalf of investors.
Continue reading
6 related stories
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 10 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
GlobeNewsWire
6h ago
